
VolitionRx Limited VNRX
€ 0.15
3.56%
Geschäftsbericht 2025
hinzugefügt 31.03.2026
VolitionRx Limited EV/EBITDA 2011-2026 | VNRX
EV/EBITDA Jährlich VolitionRx Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.45 | - | -11.2 | -4.04 | -6.02 | -7.16 | -6.29 | -11.3 | -6.37 | 339 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 339 | -11.3 | 31.4 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Agilent Technologies
A
|
27.4 | $ 116.98 | 2.73 % | $ 35.6 B | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 25.38 | 2.19 % | $ 705 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Danaher Corporation
DHR
|
20.1 | $ 196.17 | 2.7 % | $ 140 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 16.27 | 2.23 % | $ 492 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 17.97 | 1.7 % | $ 958 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-28.8 | $ 94.63 | 1.43 % | $ 11.9 B | ||
|
DexCom
DXCM
|
39.5 | $ 65.54 | 3.85 % | $ 25.6 B | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 16.28 | 1.18 % | $ 178 M | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 109.05 | 1.76 % | $ 8.99 B | ||
|
Illumina
ILMN
|
70.5 | $ 128.09 | 1.3 % | $ 20.4 B | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 174.65 | 2.42 % | $ 30 B | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 80.09 | 2.57 % | $ 5.41 B | ||
|
Charles River Laboratories International
CRL
|
22 | $ 176.44 | 4.03 % | $ 8.75 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 524.94 | 3.23 % | $ 15.1 B | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 318.47 | 3.81 % | $ 27.2 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.84 | 2.0 % | $ 448 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 8.37 | 3.85 % | $ 1.07 B | ||
|
Biodesix
BDSX
|
-4.25 | $ 14.52 | -0.08 % | $ 1.88 B | ||
|
Natera
NTRA
|
-19.5 | $ 212.81 | 1.69 % | $ 20.9 B | ||
|
OpGen
OPGN
|
0.274 | - | -16.95 % | $ 1.54 M | ||
|
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.49 | 3.12 % | $ 447 M | ||
|
PerkinElmer
PKI
|
18.8 | - | -0.91 % | $ 14.7 B | ||
|
Precipio
PRPO
|
-1.8 | $ 27.77 | -2.56 % | $ 44.6 M | ||
|
Quotient Limited
QTNT
|
-5.32 | - | -11.32 % | $ 1.1 M | ||
|
Personalis
PSNL
|
-7.07 | $ 6.48 | 5.02 % | $ 384 M | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 274.08 | 1.83 % | $ 22.8 B | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 2.68 | -0.37 % | $ 87 K | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.15 | -0.46 % | $ 4.94 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.18 | 0.85 % | $ 6.43 M | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 2.0 | 0.25 % | $ 8.85 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M |